Ross Louie E, Coates Ralph J, Breen Nancy, Uhler Robert J, Potosky Arnold L, Blackman Donald
Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341-3717, USA.
Prev Med. 2004 Jun;38(6):732-44. doi: 10.1016/j.ypmed.2004.01.005.
In 2000, the National Health Interview Survey (NHIS) collected information about prostate-specific antigen (PSA) test use in a representative sample of U.S. men.
This study examined PSA test use in subgroups defined by personal and social characteristics.
Among men aged 50 and older with no history of prostate cancer, 56.8% reported ever having had a PSA test, 34.1% reported having had a screening PSA test during the previous year, and 30.0% reported having had three or more tests during the previous 5 years. Screening was greater among men aged 60-79 years, those with greater access to care, and those practicing other preventive behaviors. Among men in their 40s, use tended to be higher among African-American men.
The prevalence and patterns of PSA screening suggest that PSA is used like other cancer screening tests among about a third of U.S. men. Because of the lack of scientific consensus on whether prostate cancer screening is beneficial, more information is needed on how knowledgeable both patients and practitioners are about the potential benefits and harms of screening and how prostate cancer screening decisions are made.
2000年,美国国家健康访谈调查(NHIS)收集了有关美国男性代表性样本中前列腺特异性抗原(PSA)检测使用情况的信息。
本研究调查了按个人和社会特征定义的亚组中PSA检测的使用情况。
在50岁及以上且无前列腺癌病史的男性中,56.8%的人报告曾进行过PSA检测,34.1%的人报告在前一年进行过PSA筛查检测,30.0%的人报告在过去5年中进行过三次或更多次检测。60 - 79岁的男性、获得医疗服务机会更多的男性以及采取其他预防行为的男性中,筛查率更高。在40多岁的男性中,非裔美国男性的检测使用率往往更高。
PSA筛查的患病率和模式表明,约三分之一的美国男性将PSA检测用于其他癌症筛查检测一样。由于在前列腺癌筛查是否有益方面缺乏科学共识,因此需要更多关于患者和从业者对筛查潜在益处和危害的了解程度以及前列腺癌筛查决策如何做出的信息。